NCT04578028View on ClinicalTrials.gov

A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of ONO-2808-01 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

August 26, 2021

Study Completion Date

October 7, 2021

Conditions
Neurodegenerative Diseases
Interventions
DRUG

ONO-2808

Investigational drug

DRUG

Placebo

Placebo drug

Trial Locations (1)

HA1 3UJ

Parexel International Early Phase Clinical Unit (EPCU), London

Sponsors

Collaborators (1)

Parexel
All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

Ono Pharmaceutical Co. Ltd

INDUSTRY